Latest News

Written by: Magmaris
1,000 Magmaris Implantations Reveal High Deployment Success and Physician Satisfaction
Written by: Reva
REVA to Expand FANTOM II Trial to More Complex Cases
Written by: Bayer
Bayer’s rivaroxaban (Xarelto® ) Provides Superior Protection Against Recurrent Venous Thromboembolism (VTE)…
Closing Left Atrial Appendage Reduces Stroke Risk from AFib
Blood Test Can Detect Heart Damage after Non-Cardiac Surgery
Pacemaker Program Can Reduce Dangerous Fainting Episodes
Evolocumab Significantly Reduces Risk of Cardiovascular Events
Self-Expanding TAVR As Good As Surgery in Intermediate-Risk Patients
Rivaroxaban Reduces VTE Recurrence Compared with Aspirin
Study Shows Benefits to Treating All Clogged Arteries at Once After Heart Attack

External news

Written by: Cardiac Vascular News
US Heart & Vascular Announces Partnership with Birmingham Heart Clinic, a leading Cardiovascular Practice in Alabama
Written by: Cardiac Vascular News
CVRx announces new CPT® Category I codes for Barostim
Written by: Cardiovascular Business
FDA says CT scans sometimes damage implantable cardiac electronic devices
Written by: Cardiovascular Business
Cardiologists make case for increasing use of device-based therapies for heart failure
Written by: Cardiovascular Business
Women less likely to survive heart surgery complications than men
Written by: Medscape
AI in Our Practice: Are We Already Part of the Experiment?
Written by: Medscape
AI in Psychiatry: Impact on Therapy & Personality Disorders
Written by: Cardiac Vascular News
HeartFlow Announces New Category I CPT Code from the American Medical Association for AI-Enabled Plaque Analysis to Assess Risk for Coronary Artery Disease
Written by: Medscape
ECG Challenge: Feeling Lightheaded After Methadone Overdose
Written by: Medscape
AI in Healthcare: Are Clinicians Ready for the Change?